Guardant Health (GH) Total Current Liabilities (2017 - 2026)
Guardant Health (GH) posted Total Current Liabilities of $339.0 million for Q2 2026, up 16.03% sequentially from $292.1 million in Q1 2026, and up 42.16% YoY from $238.4 million in Q2 2025.
Guardant Health (GH) Total Current Liabilities (2017 - 2026) Analysis & Trends
Guardant Health has reported Total Current Liabilities for 10 years, with the latest figure at $339.0 million in Q2 2026.
- Quarterly Total Current Liabilities rose 42.16% year-over-year to $339.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $339.0 million (up 42.16% YoY) and the FY2025 annual result came in at $302.7 million, up 34.2% from the prior year.
- Total Current Liabilities improved to $339.0 million in Q2 2026 per GH's latest filing, from $292.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $339.0 million in Q2 2026 and troughed at $167.8 million in Q2 2022.
- A 5-year average of $226.8 million and a median of $222.8 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 139.59% in 2022, then declined 12.97% in 2024.
- Over 5 years, Total Current Liabilities stood at $193.2 million in 2022, then rose by 6.57% to $205.9 million in 2023, then grew by 9.55% to $225.6 million in 2024, then jumped by 34.2% to $302.7 million in 2025, then rose by 11.97% to $339.0 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $339.0 million, $292.1 million, and $302.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 553.20 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 2.27 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.82 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.29 Bn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.58 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 1.20 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 2.12 Bn |
| 10 | Guardant Health | 22.38 Bn | 21.33 Bn | 219.03 Mn | 338.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 338.96 Mn |
| Mar 31, 2026 | 292.15 Mn |
| Dec 31, 2025 | 302.73 Mn |
| Sep 30, 2025 | 236.92 Mn |
| Jun 30, 2025 | 238.43 Mn |
| Mar 31, 2025 | 225.75 Mn |
| Dec 31, 2024 | 225.58 Mn |
| Sep 30, 2024 | 197.35 Mn |
| Jun 30, 2024 | 201.57 Mn |
| Mar 31, 2024 | 220.01 Mn |
| Dec 31, 2023 | 205.92 Mn |
| Sep 30, 2023 | 226.75 Mn |
| Jun 30, 2023 | 200.93 Mn |
| Mar 31, 2023 | 204.16 Mn |
| Dec 31, 2022 | 193.22 Mn |
| Sep 30, 2022 | 175.12 Mn |
| Jun 30, 2022 | 167.76 Mn |
| Mar 31, 2022 | 228.81 Mn |
| Dec 31, 2021 | 194.69 Mn |
| Sep 30, 2021 | 102.30 Mn |